Ikaros deletions are associated with poor prognosis in acute lymphoblastic leukemia

Future Oncology

Volumn 5, Issue 4, 2009, Pages 455-458

  Copland, Mhairi ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Acute lymphoblastic leukemia; B cell; DNA copy number abnormalities; Gene expression signature; Ikaros; IKZF1; Lymphoid transcription factor; Prognosis; Relapse

Indexed keywords

B LYMPHOCYTE RECEPTOR; BCR ABL PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA; EARLY B LYMPHOCYTE FACTOR 1; IKAROS TRANSCRIPTION FACTOR; LYMPHOID ENHANCER FACTOR 1; MIXED LINEAGE LEUKEMIA PROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR PAX5; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B CELL LEUKEMIA; BLOOD SAMPLING; CANCER REGRESSION; CANCER RELAPSE; CHILDHOOD LEUKEMIA; CLINICAL PROTOCOL; GENE DELETION; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 69849112542     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.09.16     Document Type: Article

References (10)

1. Mullighan CG, Su X, Zhang J et al.: Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N. Engl. J. Med. 360, 470-480 (2009).
2. Schultz KR, Pullen DJ, Sather HN et al.: Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). Blood 109, 926-935 (2007).
3. Pui CH, Robison LL, Look AT: Acute lymphoblastic leukaemia. Lancet 371, 1030-1043 (2008).
4. Molnar A, Georgopoulos K: The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol. Cell. Biol. 14, 8292-8303 (1994).
5. Georgopoulos K: Haematopoietic cell-fate decisions, chromatin regulation and ikaros. Nat. Rev. Immunol. 2, 162-174 (2002).
6. Mullighan C, Downing J: Ikaros and acute leukemia. Leuk. Lymphoma 49, 847-849 (2008).
7. Winandy S, Wu P, Georgopoulos K: A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83, 289-299 (1995).
8. Mullighan CG, Goorha S, Radtke I et al.: Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446, 758-764 (2007).
9. Mullighan CG, Miller CB, Radtke I et al.: BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 453, 110-114 (2008).
10. Pui CH, Jeha S: New therapeutic strategies for the treatment of acute lymphoblastic leukaemia. Nat. Rev. Drug Discov. 6, 149-165 (2007).